WVP
THTX

Worth Venture Partners’s Theratechnologies THTX Stock Holding History

Worth Venture Partners’s Portfolio THTX Stock Details THTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-906,557
Closed -$1.47M – 121
2023
Q4 		$1.47M Buy
906,557
+710,551
+363% +$1.07M 0.79% 47
2023
Q3 		$421K Buy
+196,006
New +$420K 0.25% 87

Other funds holding THTX

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return
HC
Hamilton Capital Columbus, Ohio $1.93B AUM

Worth Venture Partners's THTX Position: Q1 2024 in Review

Worth Venture Partners sold out of Theratechnologies (THTX) in Q1 2024, closing a stake of 906,557 shares — an estimated $1.47M sold.

Worth Venture Partners first reported a position in THTX in Q3 2023 and held it in 2 quarters. The position peaked at $1.47M in Q4 2023. 33 funds tracked by Wall St. Rank hold THTX as of Q1 2024.

  • Worth Venture Partners reported no remaining Theratechnologies position as of Q1 2024 after selling out during the quarter.
  • Worth Venture Partners sold 906,557 Theratechnologies shares in Q1 2024, an estimated $1.47M.
  • Worth Venture Partners first reported a position in Theratechnologies in Q3 2023 and held it in 2 quarters.
  • Worth Venture Partners's Theratechnologies position peaked at $1.47M in Q4 2023.
  • 33 funds tracked by Wall St. Rank held Theratechnologies as of Q1 2024.

Based on Worth Venture Partners's 13F filing for Q1 2024, filed 13 May 2024.